{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:47:56Z","timestamp":1767901676301,"version":"3.49.0"},"reference-count":40,"publisher":"Informa UK Limited","issue":"11","funder":[{"name":"National Drug Sampling Inspection"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Development and Industrial Pharmacy"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1080\/03639045.2023.2271966","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:02:59Z","timestamp":1697558579000},"page":"680-691","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the\n            <i>in\u00a0vitro<\/i>\n            performance of generic and original adapalene gel"],"prefix":"10.1080","volume":"49","author":[{"given":"Changying","family":"Xin","sequence":"first","affiliation":[{"name":"Heilongjiang Institute for Drug Control, Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Duo","sequence":"additional","affiliation":[{"name":"Heilongjiang Institute for Drug Control, Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinying","family":"Yu","sequence":"additional","affiliation":[{"name":"Heilongjiang Institute for Drug Control, Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqun","family":"Liu","sequence":"additional","affiliation":[{"name":"Heilongjiang Institute for Drug Control, Harbin, Heilongjiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011941929495"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030287"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13050710"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.06.011"},{"key":"e_1_3_2_6_1","unstructured":"US-FDA. Guidance for industry: nonsterile semisolid dosage forms scale-up and post approval changes: chemistry manufacturing and controls; in\u00a0vitro release testing and in\u00a0vivo bioequivalence documentation (SUPAC-SS). Rockville MD: US-FDA; 1997."},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.07.003"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2016.06.098"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2021.078"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122159"},{"key":"e_1_3_2_11_1","unstructured":"US-FDA. Physicochemical and structural (Q3) characterization of topical drug products submitted in ANDAs guidance for industry; Rockville MD: US-FDA; 2022."},{"key":"e_1_3_2_12_1","unstructured":"US-FDA. In vitro release test studies for topical drug products submitted in ANDAs guidance for industry. Rockville MD: US-FDA; 2022."},{"key":"e_1_3_2_13_1","unstructured":"US-FDA. In vitro permeation test studies for topical drug products submitted in ANDAs guidance for industry. Rockville MD: US-FDA; 2022."},{"key":"e_1_3_2_14_1","unstructured":"PMDA: Q&A on bioequivalence test guidelines for formulation changes of topical skin application formulations (semisolid formulations and patches); November 2010."},{"key":"e_1_3_2_15_1","unstructured":"European Medicine Agency. Committee for MedicinalProducts for Human use (CHMP). Draft guideline on quality and equivalence of topical products; December 2018."},{"key":"e_1_3_2_16_1","unstructured":"US-FDA. Draft guidance on acyclovir; December 2016."},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121186"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119914"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2021.1957921"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/10837450.2021.1945625"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091892"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040555"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph13090217"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/gels9020135"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.5530\/jyp.2021.13.49"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104149"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6889293"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2018.04.029"},{"issue":"1","key":"e_1_3_2_29_1","first-page":"871","article-title":"Intradermal and follicular delivery of adapalene liposomes","volume":"42","author":"Vijay K","year":"2015","unstructured":"Vijay K, Ajay KB. Intradermal and follicular delivery of adapalene liposomes. Drug Dev Ind Pharm. 2015;42(1\/6):871\u2013879.","journal-title":"Drug Dev Ind Pharm"},{"key":"e_1_3_2_30_1","volume-title":"USP chapter <1724> PF 48(3) semisolid drug products \u2013 performance tests, United States pharmacopeia and national formulary (USP 43-NF 38)","author":"FDA","year":"2022","unstructured":"FDA. 2022. USP chapter <1724> PF 48(3) semisolid drug products \u2013 performance tests, United States pharmacopeia and national formulary (USP 43-NF 38). Rockville, MD: united States Pharmacopeial Convention."},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120657"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103314"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091975"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13060809"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/membranes11010057"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(97)70055-0"},{"key":"e_1_3_2_37_1","first-page":"339","article-title":"Correlation between rheological properties and in\u00a0vitro drug release from penetration Enhancer-Loaded carbopol\u00ae gels","volume":"11","author":"Rania H","year":"2016","unstructured":"Rania H, Tamadur AB, Ahlam ZA, et\u00a0al. Correlation between rheological properties and in\u00a0vitro drug release from penetration Enhancer-Loaded carbopol\u00ae gels. J Pharmaceut Innovat. 2016;11:339\u2013351.","journal-title":"J Pharmaceut Innovat"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118684"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1023\/b:pham.0000033006.11619.07"},{"issue":"5","key":"e_1_3_2_40_1","first-page":"1235","article-title":"Based on clinical application research progress of their mosensitive gel in different drug delivery sites","volume":"57","author":"Fan R","year":"2022","unstructured":"Fan R, Liu Y, Zhang T, et\u00a0al. Based on clinical application research progress of their mosensitive gel in different drug delivery sites. Acta Pharmaceutica Sinica. 2022;57(5):1235\u20131244.","journal-title":"Acta Pharmaceutica Sinica"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11120671"}],"container-title":["Drug Development and Industrial Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03639045.2023.2271966","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T15:14:13Z","timestamp":1727190853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03639045.2023.2271966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1080\/03639045.2023.2271966"],"URL":"https:\/\/doi.org\/10.1080\/03639045.2023.2271966","relation":{},"ISSN":["0363-9045","1520-5762"],"issn-type":[{"value":"0363-9045","type":"print"},{"value":"1520-5762","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iddi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-05-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}